Scope Fluidics S.A. (WSE:SCP)
143.40
-1.00 (-0.69%)
Jan 28, 2026, 4:49 PM CET
Scope Fluidics Market Cap
Scope Fluidics has a market cap or net worth of 457.5 million as of January 28, 2026. Its market cap has decreased by -0.81% in one year.
Market Cap
457.50M
Enterprise Value
349.22M
Revenue
718.00K
Ranking
n/a
PE Ratio
7.23
Stock Price
143.40
Market Cap Chart
Since August 16, 2017, Scope Fluidics's market cap has increased from 41.31M to 457.50M, an increase of 1,007.37%. That is a compound annual growth rate of 32.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 457.50M | 6.02% |
| Dec 30, 2025 | 431.52M | -3.47% |
| Dec 30, 2024 | 447.05M | -16.33% |
| Dec 29, 2023 | 534.28M | -5.54% |
| Dec 30, 2022 | 565.63M | 54.38% |
| Dec 30, 2021 | 366.40M | 1.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.54B |
| NEUCA | 3.60B |
| Synektik Spólka Akcyjna | 2.58B |
| Voxel | 1.45B |
| Ryvu Therapeutics | 611.53M |
| Captor Therapeutics Spolka Akcyjna | 447.83M |
| Bioceltix | 385.59M |
| Mercator Medical | 377.70M |